166 related articles for article (PubMed ID: 3178240)
1. [BH-AC.AMP protocol in the treatment of refractory childhood acute leukemia].
Nakadate H; Hatayama Y; Hatae Y; Takeda T
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2907-10. PubMed ID: 3178240
[TBL] [Abstract][Full Text] [Related]
2. [Combination chemotherapy of N(4)-behenoyl-1-beta-arabinofuranosylcytosine, aclarubicin, 6-MP, and prednisolone (BH-AC. AMP therapy) for adult acute non-lymphocytic leukemia].
Ishige K; Takagi T; Oguro M
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1475-9. PubMed ID: 6588925
[TBL] [Abstract][Full Text] [Related]
3. [Experience with using aclarubicin in the treatment of acute leukemia and blast crisis of chronic myeloid leukemia].
Savchenko VG; Isaev VG; Abakumov EM; Khoroshko ND; Turkina AG; Sokolov AN; Viadro MM; Navashin SM
Antibiot Khimioter; 1992 Jul; 37(7):47-9. PubMed ID: 1456812
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of acute myelogenous leukemia with concurrent administration of N4-behenoyl-ara-C, aclacinomycin A, 6-mercaptopurine and prednisolone].
Ino T; Saito M; Matsui T; Shimizu S; Shigemura H; Nakamura K; Ono Y; Okamoto M; Takada T; Imura H
Rinsho Ketsueki; 1985 Feb; 26(2):139-46. PubMed ID: 3860668
[No Abstract] [Full Text] [Related]
5. [Evaluation of 58 patients with acute leukemia].
Sasaki A; Tsukaguchi M
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1303-7. PubMed ID: 1503484
[TBL] [Abstract][Full Text] [Related]
6. Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia.
Feldman EJ; Alberts DS; Arlin Z; Ahmed T; Mittelman A; Baskind P; Peng YM; Baier M; Plezia P
J Clin Oncol; 1993 Oct; 11(10):2002-9. PubMed ID: 8410125
[TBL] [Abstract][Full Text] [Related]
7. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D
Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434
[TBL] [Abstract][Full Text] [Related]
8. Nationwide randomized comparative study of daunorubicin and aclarubicin in combination with behenoyl cytosine arabinoside, 6-mercaptopurine, and prednisolone for previously untreated acute myeloid leukemia.
Nagura E; Kimura K; Yamada K; Ohta K; Maekawa T; Takaku F; Uchino H; Masaoka T; Amaki I; Kawashima K
Cancer Chemother Pharmacol; 1994; 34(1):23-9. PubMed ID: 8174198
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of refractory acute lymphocytic leukemia in childhood with BH-AC, ACM, 6-MP, and prednisolone].
Karube T; Maehara M; Ijima H; Muchi H
Rinsho Ketsueki; 1984 May; 25(5):613-8. PubMed ID: 6590894
[No Abstract] [Full Text] [Related]
10. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
[TBL] [Abstract][Full Text] [Related]
11. [A study of combination chemotherapy (BHAC-ACVP) for adult acute lymphocytic leukemia. Hanshin Co-operative Study Group of Hematological Malignancies].
Kanamaru A; Kakishita E; Nagai K; Masaoka T; Horiuchi A; Kitani T; Yasunaga K; Kawagoe H; Tatsumi N; Kageyama T
Gan To Kagaku Ryoho; 1992 Jan; 19(1):49-54. PubMed ID: 1729960
[TBL] [Abstract][Full Text] [Related]
12. [Gastrointestinal symptoms of aclacinomycin A in patients with adult acute nonlymphocytic leukemia--comparison of BH-AC-DMP therapy and BH-AC-AMP therapy].
Kawano F; Tajima H; Matsuoka Y; Asou N; Takatsuki K
Rinsho Ketsueki; 1985 Apr; 26(4):494-8. PubMed ID: 3862889
[No Abstract] [Full Text] [Related]
13. Phase I/II study of idarubicin given with continuous infusion fludarabine followed by continuous infusion cytarabine in children with acute leukemia: a report from the Children's Cancer Group.
Dinndorf PA; Avramis VI; Wiersma S; Krailo MD; Liu-Mares W; Seibel NL; Sato JK; Mosher RB; Kelleher JF; Reaman GH
J Clin Oncol; 1997 Aug; 15(8):2780-5. PubMed ID: 9256119
[TBL] [Abstract][Full Text] [Related]
14. [Mucosal injury of aclacinomycin A in patients with adult acute leukemia--comparison of BH-AC. AMP therapy and BH-AC. DMP therapy].
Takeyama H; Kataoka T; Yano K; Fukutani H; Watanabe E
Rinsho Ketsueki; 1986 Apr; 27(4):508-13. PubMed ID: 3461186
[No Abstract] [Full Text] [Related]
15. Effective reinduction therapy for childhood acute nonlymphoid leukemia using simultaneous continuous infusions of teniposide and amsacrine.
Mirro J; Kalwinsky DK; Grier HE; Santana VM; Mason C; Murphy SB; Dahl GV
Cancer Chemother Pharmacol; 1989; 24(2):123-7. PubMed ID: 2731312
[TBL] [Abstract][Full Text] [Related]
16. [Progress of chemotherapy in adult acute leukemia].
Ohno R
Gan To Kagaku Ryoho; 1995 Mar; 22(4):431-6. PubMed ID: 7887634
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute non-lymphocytic leukemia with alternating non-cross resistant chemotherapy.
Kyo T; Dohy H
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1641-52. PubMed ID: 3247827
[No Abstract] [Full Text] [Related]
18. [A case of acute promyelocytic leukemia complicated with severe esophageal stenosis caused by aclacinomycin A].
Kataoka T; Takeyama H; Watanabe E; Yano K
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1686-9. PubMed ID: 3861136
[TBL] [Abstract][Full Text] [Related]
19. [Treatment results of acute nonlymphocytic leukemia in childhood--Kyushu Yamaguchi Children's Cancer Study Group].
Ikuno Y; Okamura J; Ishii E; Matuzaki A; Ueda K; Eguchi H; Inada H; Nibu K; Koga H; Miyazaki S
Rinsho Ketsueki; 1995 Apr; 36(4):325-33. PubMed ID: 7783338
[TBL] [Abstract][Full Text] [Related]
20. Behenoyl cytosine arabinoside, aclacinomycin A, 6-mercaptopurine, and prednisolone combination therapy for acute non-lymphocytic leukaemia in adults.
Yoshida M; Suda K; Tsuboyama A; Sasaki R; Kitagawa S; Kano Y; Muto Y; Takaku F; Sakamoto S; Miura Y
Eur J Haematol; 1989 Jul; 43(1):1-6. PubMed ID: 2767238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
